Fusion hybrid of dendritic cells and engineered tumor cells expressing interleukin-12 induces type 1 immune responses against tumor. (Q40320955)
Jump to navigation
Jump to search
scientific article published on November 2005
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Fusion hybrid of dendritic cells and engineered tumor cells expressing interleukin-12 induces type 1 immune responses against tumor. |
scientific article published on November 2005 |
Statements
Fusion hybrid of dendritic cells and engineered tumor cells expressing interleukin-12 induces type 1 immune responses against tumor (English)
Meiqing Shi
Liping Su
Sigou Hao
Xulin Guo
1 November 2005